GlaxoSmithKline Shs Sponsored American Deposit Receipt Repr 2 Shs $47.68

down -0.02


22/8/2014 04:00 PM  |  NYSE : GSK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get GSK Trend Analysis - it has underperformed the S&P 500 by 28%

Partner Headlines

  1. UPDATE: GlaxoSmithKline Receives FDA Approval For Arnuity Ellipta In US ...

    Benzinga
  2. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, MFG

    GuruFocus
  3. Intermune up on buyout buzz

    IBD
  4. You Should Consider Adding GlaxoSmithKline Based on Tremendous ROE

    GuruFocus
  5. Drugmaker AstraZeneca Returns To Growth

    IBD
  6. Widely Held Guru Stocks Near 52-Week Lows

    GuruFocus
  7. Pfizer To Buy Baxter's Vaccines For $635 Million: The Positives & Negatives

    Benzinga
  8. Glaxo, Sanofi Trend Up On Potential Deal For Established Brands

    Benzinga
  9. Guru Stocks at 52-Week Lows: PFE, GSK, VOD, EC, UBS

    GuruFocus
  10. Glaxo, Genmab Report Positive Interim Result for Phase III Study of Ofatumumab

    Benzinga
  11. A Look at the Week's Top Dividend Growers

    GuruFocus
  12. Markets Little Changed Ahead Of The Federal Reserve's Policy Decision

    Benzinga
  13. GlaxoSmithKline

    IBD
  14. Stock Futures Up, But Wobbly; Boeing, Apple, Biogen Rising

    IBD
  15. Mylan Wins Motion To Enjoin GlaxoSmithKline From Providing Paroxetine CR ...

    Benzinga
  16. Morning Market Movers

    Benzinga
  17. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With The Highest ...

    Benzinga
  18. Highest Yielding Stocks Widely Held By The Gurus

    GuruFocus
  19. British Stocks: Sweet Spot For European Value

    YCharts
  20. Diamond Hill Capital Comments on GlaxoSmithKline PLC

    GuruFocus
  21. ISIS Pharma Trades Up Premarket; NYT Says Has Potential Heart Attack Drug

    Benzinga
  22. Advances In HIV, Hep C Treatments Could Spark Renewed Interest In Biotech ...

    Benzinga
  23. InterMune Up On Bullish View Of U.S. Esbriet Launch

    IBD
  24. UPDATE: Glaxo, Theravance Report Positive Data from Two Studies Considering ...

    Benzinga
  25. Major British Companies Lead Top Guru-Held UK and Ireland Stocks

    GuruFocus
  26. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  27. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica & Targeted ...

    Benzinga
  28. Aura Of Light Shines On Pernix Shares Following Treximet Acquisition

    Benzinga
  29. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  30. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  31. Can Pfizer Make Up Its Loss?

    GuruFocus
  32. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  33. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  34. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  35. #PreMarket Primer: Thursday, May 1: Fed Brushes Off Dissapointing GDP And ...

    Benzinga
  36. Glaxo hurt by Advair scandal

    IBD
  37. Nasdaq Leads Early Stock Slide; Twitter Tumbles, Trinity Rises

    IBD
  38. Stock Futures Slip as Traders Brace for Economic Flood

    FoxBusiness
  39. Disappointing GDP Reading Weighs on Stocks

    FoxBusiness
  40. China Rule Change Further Opens Yuan To World Markets

    IBD
  41. Weekly 52-Week Highs Highlight: AV, XEL, OKE, GSK

    GuruFocus
  42. GSK, MMV Announce Commencement of Phase III Programme of Tafenoquine for ...

    Benzinga
  43. These Three Pharmaceutical Companies Shake The Market With Their Deal

    GuruFocus
  44. Benzinga Weekly Preview: Earnings Season Continues As Biotech & Pharmaceutical ...

    Benzinga
  45. Big Pharmas Swap Specialties

    IBD
  46. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  47. Valeant's Bid For Allergan Boosts Ethical Drug Stocks

    IBD
  48. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  49. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  50. S&P 500, Nasdaq Rise For Sixth Day As Volume Picks Up

    IBD
Trading Center